The aim of this work was to compare the efficiency of standard intrauterine insemination (IUI) and Fallopian tube sperm perfusion (FSP) in the treatment of infertility. Ninety-six consecutive patients with infertility in 100 cycles were included in the study. Those randomized to standard IUI included 48 patients in 50 cycles [25 clomiphene citrate only and 25 clomiphene citrate/human menopausal gonadotrophin (HMG) cycles] (group I). Patients subjected to FSP included 48 patients in 50 cycles (18 clomiphene citrate only and 32 clomiphene citrate/HMG cycles) (group II). The overall pregnancy rate per cycle (16% versus 18%) was not significantly different in the two groups. The pregnancy rates were also similar in the two groups when compared for the cause of infertility: ovulatory disorder 16.7% versus 16%, tubal impairment 10% versus 9.1%, cervical hostility (no pregnancy occurred in this group) and unexplained infertility 21.4% versus 25%. The overall pregnancy rate (for the two groups) appeared higher when clomiphene citrate/HMG was used for ovulation induction (21.1%) than when clomiphene citrate only was used (11.6%).
Introduction
Intrauterine insemination (IUI) has been used for many years in the treatment of infertile couples. During IUI, pretreated semen is concentrated in a small volume of 0.2-0.5 ml (Sunde and Kahn, 1988; Urry et al., 1988; Patton et al., 1990) and deposited by a catheter into the uterine cavity. The overall pregnancy rates reported in the literature rarely exceed 15% per cycle (Mastroianni et al., 1957; Allen et al., 1985; Youich and Matson, 1988; Dodson and Hang, 1991; Karande et al., 1995; Vollenhoven et al., 1996; Zayed et al., 1997) .
Recently, an alternative procedure, termed Fallopian tube sperm perfusion (FSP), has been reported with allegedly improved pregnancy rates in comparison with IUI (Kahn et al., 1992; Li, 1993; Arroya Vieyra et al., 1995; Fanchin et al., 1995; Mamas, 1996) . In FSP, sperm preparation is identical to that used with IUI, but spermatozoa are diluted in a larger volume of medium (4 ml) (Kahn et al., 1992; Karande et al., 1995; Huttunen et al., 1997) , thus allowing spermatozoa not only to be deposited in the uterine cavity, but also to perfuse the Fallopian tubes and be expelled into the cul-de-sac.
Since previous reports showed a potential pregnancy benefit of FSP over IUI, a prospective randomized study was designed to determine whether FSP resulted in higher pregnancy rates than IUI and to compare the results in relation to the aetiology of infertility.
Materials and methods
Ninety-six infertile patients, aged 17 to 39 years, undergoing 100 consecutive cycles of ovarian stimulation were studied from June 1995 to June 1997. These patients underwent a basic infertility workup, including confirmation of tubal status by hysterosalpingogram or laparoscopy; hormonal profile, including serum follicle stimulating hormone, luteinizing hormone as well as prolactin levels; and repeated properly timed post-coital tests. Exclusion criteria were age Ͼ39 years, obstructed tubes, oestradiol concentration per mature follicle (ജ17 mm in diameter) Ͻ250 pg/ml on the day of human chorionic gonadotrophin (HCG) treatment, and cases with male infertility (marked oligoasthenozoospermia). The patients were classified as having tubal impairment (light peritubal adhesions or slightly reduced tubal fimbriae and/or moderate loss of gracility of the tubes); ovulatory disorders (most of them showed hormonal profile characteristic of polycystic ovarian syndrome); cervical hostility (repeated poor properly timed post-coital tests); or unexplained infertility (no infertility cause was found: post-coital tests were normal, males produced normal spermatozoa and antisperm antibodies were not detected in serum). These patients underwent ovulation induction with either clomiphene citrate alone (Clomid, Merrel-Dow, Paris, France) or clomiphene citrate and human menopausal gonadotrophin (HMG) (Pergonal, Serono, Rome, Italy).
Cycles were monitored from day 9 by repeated measurement of serum oestradiol and transvaginal ultrasound measurement of the number and diameter of the growing follicles. The maturation of two to four follicles was considered optimal. A dose of 10 000 IU HCG (Pregnyl, Nile Co., Cairo, Egypt) was administered when at least one follicle had reached a diameter of 17-18 mm, and 34-36 h later, either standard IUI (group I: 50 cycles in 48 patients) or FSP (group II: 50 cycles in 48 patients) was performed. The patients were counselled about the two alternative procedures and informed consents were obtained before randomization. Patients were allocated randomly to standard IUI (group I, 50 cycles) or FSP (group II, 50 cycles) on the day of the insemination, according to a blocked randomization list.
All male partners were normozoospermic with count Ͼ20ϫ10 6 sperm per ml, Ͼ50% motile with forward progression (categories a and b) within 60 min of ejaculation and Ͼ60% morphologically normal spermatozoa (WHO, 1992) . A fresh ejaculate was delivered by masturbation on the day of insemination after 3 days of abstinence, and a classical swim-up technique was used (Sher et al., 1984) for its preparation. Frydman catheters (CCD Laboratories, Paris, France) were used for IUI as well as FSP. However, during FSP the spermatozoa were suspended in 4 ml of media (Ham's F10, Gibco BRL, Paisley, Scotland), whereas for IUI the volume was usually less than 0.5 ml. During FSP, the insemination was carried out over 4 min and an Allis clamp was kept in place for about 3 to 4 min after insemination. For IUI, insemination occurred by the plunger action of a syringe. In both groups, the patients rested for 30 min after insemination and received oral micronized progesterone (Utrogestan, Piette, Paris, France) 100 mg, two tablets per day for luteal-phase support.
Values were recorded as mean Ϯ SD. Statistical analysis was performed using a computer program Microsoft Excel version 4 with Student's t-test for testing the significance of difference between the means and the χ 2 test for testing the agreement between observation and hypothesis (discrete data). A P-value of 0.05 was considered as significant.
Results
The patient characteristics for group I and II were not significantly different concerning patient's age (31.5 Ϯ 5.3 years and 32.0 Ϯ 5.2 years, respectively), type of sterility (primary infertility 74% versus 72%, respectively), duration of infertility (8.6 Ϯ 2.1 and 7.3 Ϯ 1.9 years, respectively), and clinical indication for ovarian stimulation (partial tubal damage 20% versus 22%, ovulatory 48% versus 50%, cervical 4% versus 4% and unexplained 28% versus 24%). Ovarian stimulation, peak oestradiol concentrations, number of follicles, day of HCG, endometrial thickness on the day of HCG and the number of spermatozoa inseminated were not significantly different as shown in Table I .
There was no significant difference in the overall pregnancy rate per cycle (16% versus 18%, respectively) for IUI (group I) and FSP (group II) (Table II) . Rates were also similar when compared for the aetiology of infertility: for ovarian cause (16.7% versus 16%), tubal cause (10% versus 9.1%), and for unexplained infertility (21.4% versus 25%) for the two groups, respectively. Clinical pregnancy, defined as presence of fetal heart beats at the ultrasound scan at 6 weeks amenorrhoea, and its outcome in both groups are represented in Tables II and III . In IUI patients (group I), eight pregnancies occurred (16% per cycle), of which seven delivered (one had twins) and one patient who had triplets aborted at 10 weeks. In FSP patients (group II), nine clinical pregnancies occurred (18% per cycle), of which eight delivered (two patients had twins) and one aborted at 9 weeks. The prevalence of twin and triplet pregnancies in the There were no significant differences. PR ϭ pregnancy rate; HMG ϭ human menopausal gonadotrophin; FSP ϭ Fallopian tube sperm perfusion; IUI ϭ intrauterine insemination.
study groups was different: one of eight (12.5%) and one of eight (12.5%), respectively, in group I, and two of nine (22.2%) and none of nine in group II. However, this limited number is too low to allow testing for statistical significance. The overall pregnancy rate (for the two groups together) appeared higher when clomiphene citrate/HMG was used for ovarian stimulation (21.1%) than when clomiphene citrate only (11.6%) was used (Table IV) but the difference was not statistically significant. Kahn et al. (1992) reported the first clinical experience with FSP. In their study, they used a Frydman catheter for FSP and reported a pregnancy rate per cycle of 26.9% in patients with unexplained infertility and of 2.7% to 7.7% in patients with other aetiologies. These excellent results, particularly in patients with unexplained infertility, were confirmed by other studies (Oei et al., 1992; Arroyo Vieyra et al., 1995; Fanchin et al., 1995; Mamas, 1996) . Some investigators used a paediatric Foley catheter (Li, 1993; Huttunen et al., 1997) , a cervical clamp double-nut bivalve speculum (Mamas, 1996) and an autoblocking device (FAST system) (Fanchin et al., 1995) for FSP instead of the Frydman catheter. Fanchin et al. (1995) stated that the high pregnancy rate per cycle for FSP as compared with standard IUI (40% versus 20%, respectively) is due to several causes as follows: first, the pressure injection of inseminate can either remove and/or circumvent transitory or partial obstruction of Fallopian tubes, such as that created by thick mucus or tubal polyps; second, the concentration of motile spermatozoa around the oocyte after FSP is higher than that obtained after standard IUI; and third, FSP leads to the inseminate overflowing into the pouch of Douglas.
Discussion
In this study, we tried to evaluate FSP not only in patients with unexplained infertility but also in patients with other causes of infertility excluding male causes. Two different stimulation regimes were used; however, the distribution of the two types of stimulation protocols (clomiphene citrate only and clomiphene citrate/HMG) appeared homogeneous in both studied groups. Using a Frydman catheter, the overall pregnancy rate with FSP is low compared with that reported by and is not significantly higher than that with standard IUI. When comparing the pregnancy rates in both IUI and FSP in relation to the aetiology of infertility, 3055 they were found to be statistically similar. Although the pregnancy rate in the unexplained infertility patients was higher than in patients with other aetiologies of infertility, there was no significant difference between the IUI-allocated patients and the FSP-allocated patients. This suggests that FSP offers no advantage over the conventional IUI technique, and this conclusion is similar to that of other investigators (Gregoriou et al., 1995; Karande et al., 1995; Huttunen et al., 1997) .
From this study we conclude that FSP, using a Frydman catheter, offers no advantage over the standard IUI and is more time-consuming and more expensive due to the increased media usage and staff time. However, the very encouraging results reported by Fanchin et al. (1995) in which FSP using an autoblocking device (FAST system) doubled their pregnancy rate from 20% to 40% makes it worth consideration.
